Bionano Genomics (BNGO) said Tuesday it agreed to settle and amend its outstanding senior secured convertible debentures due May 26, 2024.
The company said the amendment defers its December 2024 amortization payment, reduces payment due in January 2025 through July to $500,000 a month from $1 million, and increases payments due starting in August to about $1.375 million a month from $1 million until the debt is paid in full.
Under the amendment, Bionano decreased the conversion price to $0.27 from $2 and agreed to issue the debt holders 5 million common shares.
Price: 0.27, Change: -0.01, Percent Change: -4.51
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。